HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

Lecanemab Represents Promising Therapy for Alzheimer Disease, Posts Positive Phase 3 Secondary Analyses

November 30, 2022

By Marco Meglio

In the pivotal phase 3 Clarity AD trial, lecanemab (Biogen) demonstrated significant impacts on primary and secondary end points, with additional promising results on biomarker analyses and safety.

CGRP Antagonist Atogepant Improves Patient-Reported Outcomes as Migraine Preventive

November 29, 2022

By Marco Meglio

In a post-hoc analysis of the ADVANCE trial, atogepant 30 and 60 mg produced significant improvements in outcomes on Migraine-Specific Quality of Life Questionnaire and Activity Impairment in Migraine-Diary domains.

Using Nonpharmacological Interventions to Promote Healthier Lifestyles in Multiple Sclerosis

November 29, 2022

By Isabella Ciccone, MPH

Michelle Chen, PhD, neuropsychologist at Rutgers University, spoke about her current research grant on the longitudinal impact of health and lifestyle behaviors on cognition with MS.

AXS-05 Meets Primary End Point in Phase 3 Trial of Alzheimer Agitation

November 29, 2022

By Marco Meglio

Treatment with the investigational agent resulted in improvements in Alzheimer disease agitation, as well as significant delays in time to relapse and prevention of relapse.

Insomnia Diagnosis During Pregnancy Increased in the United States, Analysis Shows

November 28, 2022

By Isabella Ciccone, MPH

A recent cross-sectional analysis showed an increase in coded diagnoses of insomnia during pregnancy in the United States over time.

Featured


Latest Videos


Most Recent